CrossrefInfokarte
The pTau217/Aβ1-42 plasma ratio: The first FDA-cleared blood biomarker test for diagnosis of Alzheimer's disease
Drug Discoveries & Therapeutics · 2025-06-30 · 19 (3) · 208-209
DOI: 10.5582/ddt.2025.01055 ↗Abstract
Kein Abstract verfügbar.
EUVIMED